TrialArthritis research & therapy2025

Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.

Shuji Asai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.